Dotter
Dotter provides diagnostic and therapeutic tools to improve diagnosis and treatment of cardiovascular disease using advanced in vivo imaging and implantable devices. The company develops Optical Coherence Tomography (OCT) systems and catheters integrated with AI-powered risk analysis and the Benetis-Lifetime OCT‑FLIm platform for combined OCT and fluorescence lifetime imaging. For treatment it designs bioresorbable stents (BRS) using MPC technology, a V-shaped stent design and laser processing to produce thinner struts and controlled drug elution. Dotter sells its medical devices and imaging systems primarily to hospitals, interventional cardiologists, and healthcare providers for use in clinical cardiology workflows.
Dotter
Dotter provides diagnostic and therapeutic tools to improve diagnosis and treatment of cardiovascular disease using advanced in vivo imaging and implantable devices. The company develops Optical Coherence Tomography (OCT) systems and catheters integrated with AI-powered risk analysis and the Benetis-Lifetime OCT‑FLIm platform for combined OCT and fluorescence lifetime imaging. For treatment it designs bioresorbable stents (BRS) using MPC technology, a V-shaped stent design and laser processing to produce thinner struts and controlled drug elution. Dotter sells its medical devices and imaging systems primarily to hospitals, interventional cardiologists, and healthcare providers for use in clinical cardiology workflows.